// home

Latest Post

Personalized Lymphoma Vaccine Is Granted Orphan Drug Status in the United States

A personalized vaccine for lymphoma, BiovaxID (developed by Biovest International), has been granted orphan drug status by the US Food and Drug Administration, which will grant it a 7-year period of market exclusivity after approval. It is one of a few late-stage patient-specific cancer vaccines vying to be the first to reach the market, according [...]

Hematopathologist's Gold Standard: WHO Classification of Lymphoma "This book remains THE 'must-have' concise reference on haematopoetic and lymphoid neoplasms. With strong emphasis on diagnostic features and essential 'need to know' information for each neoplastic entity, organised on the backdrop of the current WHO classification and augmented by superb photographic plates and ...

Recent Posts

  • WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue

    Hematopathologist’s Gold Standard: WHO Classification of Lymphoma
    “This book remains THE ‘must-have’ concise reference on haematopoetic and lymphoid neoplasms. With strong emphasis on diagnostic features and essential ‘need to know’ information for each neoplastic entity, organised on the backdrop of the current WHO classification and augmented by superb photographic plates and illustrations, this text represents an [...]

  • Exercise Is Good Medicine For Lymphoma Patients

    The Healthy Exercise for Lymphoma Patients (HELP) trial, a three-year study led by Kerry Courneya, Canada Research Chair in physical activity and cancer in the Faculty of Physical Education and Recreation, found that a regimen of aerobic exercise training produced significant improvements in physical functioning and overall quality of life benefits in patients with lymphoma.
    Researchers [...]

  • National Pathology Week 3-9 November

    National Pathology Week 3-9 November – Royal College Of Pathologists
    14 Oct 2008
    The Royal College of Pathologists and other specialist societies are holding the first National Pathology Week from 3-9 November 2008 to promote pathology. Over 150 fun free events are being held in hospitals and communities all over the United Kingdom and [...]

  • 2008 Lymphoma Drug Pipeline Update

    Lymphoma Drug Pipeline Update 2008, Bioseeker, April 2008
    Lymphoma is a broad term encompassing a variety of cancers of the lymphatic system. There are today more than 180 therapeutics targeting lymphoma, from early preclinical to marketed drugs. Lymphoma Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified [...]

  • New Cancer Target for Non-Hodgkin’s Lymphoma

    Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin’s lymphoma, a type of cancer that affects lymphocytes, or white blood cells. By exploiting this mechanism, researchers have been able to powerfully suppress tumor formation in lab testing and in animal [...]

  • FLOW CYTOMETRY PROTOCOL

    BLOOD SAMPLE PREPARATION
    • For each 1 ml of blood, add 14 ml of room temperature FCM Lysing solution to lyse the red blood cells. The cells will not lyse correctly if the solution is cold.
    • Incubate for 5 minutes at room temperature. Do not exceed 5 minutes, as the white blood cells will begin to [...]

  • Formaldehyde Tied to Blood and Lymphatic Cancers

    Exposure to formaldehyde may be linked to blood and lymphatic cancers, particularly myeloid leukemia and lymphoma.
    In an extended analysis of workers exposed to formaldehyde during their careers, the agent was associated with a 37% increased risk of death from such cancers in those with the highest exposures according to Laura E. Beane Freeman, Ph.D., of [...]

Welcome to hematopathologist.com

Hematopathology is a medical specialty focused on diseases of blood and lymphatic system. Hematopathologists are diagnosticians or physicians who make diagnosis of theses disease based on morphology, lab results and clinical information. Leukemia and lymphoma are the two major diseases of this specialty.